KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeNon-Interest IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kopin (KOPN) Research & Development (2016 - 2025)

Kopin's Research & Development history spans 16 years, with the latest figure at $127656.0 for Q4 2025.

  • Quarterly results put Research & Development at $127656.0 for Q4 2025, up 118.13% from a year ago — trailing twelve months through Dec 2025 was $6.7 million (up 14.73% YoY), and the annual figure for FY2025 was $6.7 million, up 14.73%.
  • Research & Development for Q4 2025 was $127656.0 at Kopin, down from $2.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.4 million in Q1 2022 to a low of -$5.6 million in Q4 2022.
  • The 5-year median for Research & Development is $2.4 million (2023), against an average of $1.5 million.
  • The sharpest move saw Research & Development plummeted 57.25% in 2023, then skyrocketed 118.13% in 2025.
  • Year by year, Research & Development stood at -$4.7 million in 2021, then dropped by 18.22% to -$5.6 million in 2022, then rose by 12.0% to -$4.9 million in 2023, then skyrocketed by 85.73% to -$704283.0 in 2024, then skyrocketed by 118.13% to $127656.0 in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $127656.0, $2.5 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.